English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51776234    Online Users :  947
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"chun jen liu"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 206-255 of 543  (11 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-24T09:31:38Z Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence CHUN-JEN LIU; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:38Z Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages CHUN-JEN LIU; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:38Z Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:37Z Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection Song L.-W.; Liu P.-G.; CHUN-JEN LIU; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; Chen P.-J.; Xia N.-S.
臺大學術典藏 2022-01-24T09:31:37Z Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:37Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:36Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:36Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:36Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:35Z Development of risk scoring system for stratifying population for hepatocellular carcinoma screening Hung Y.-C.; Lin C.-L.; CHUN-JEN LIU; Hung H.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chuang S.-C.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:35Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; CHUN-JEN LIU; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-24T09:31:34Z Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2022-01-24T09:31:34Z Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus Chen H.-L.; Lee C.-N.; Chang C.-H.; Ni Y.-H.; Shyu M.-K.; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; Chan K.A.; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; CHUN-JEN LIU; Su T.-H.; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study)
臺大學術典藏 2022-01-24T09:31:33Z Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; Hsu S.-J.; Lai H.-C.; Su C.-W.; CHUN-JEN LIU; Peng C.-Y.; Yu M.-L.
臺大學術典藏 2022-01-24T09:31:33Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; CHUN-JEN LIU; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:33Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:32Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2022-01-24T09:31:32Z Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study Huang Y.-W.; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; CHUN-JEN LIU; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-24T09:31:31Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:31Z Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; Chen P.J.; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; Kao J.H.
臺大學術典藏 2022-01-24T09:31:31Z Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model Li Y.-T.; CHUN-JEN LIU; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏 2022-01-24T09:31:30Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H.; CHUN-JEN LIU; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:30Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:30Z Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis Yang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; CHUN-JEN LIU; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; Kao J.-H.; Chen C.-J.
臺大學術典藏 2022-01-24T09:31:29Z Perspectives on dual hepatitis B and C infection in Taiwan CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Tseng T.-C.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:29Z Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients Wu H.-L.; Hsiao T.-H.; Chen P.-J.; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:29Z Asian consensus on the relationship between obesity and gastrointestinal and liver diseases Koh J.C.; Loo W.M.; Goh K.L.; Sugano K.; Chan W.K.; Chiu W.Y.P.; Choi M.-G.; Gonlachanvit S.; Lee W.-J.; Lee W.J.J.; Lee Y.Y.; Lesmana L.A.; Li Y.-M.; CHUN-JEN LIU; Matsuura B.; Nakajima A.; Ng E.K.W.; Sollano J.D.; Wong S.K.H.; Wong V.W.S.; Yang Y.; Ho K.Y.; Dan Y.Y.
臺大學術典藏 2022-01-24T09:31:28Z Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU; Chen P.; Lin S.-M.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:28Z Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure Shi X.; Zhu P.; Yan G.; CHUN-JEN LIU; Zhang C.; Huang G.; Zhang Y.; Yan Z.; Wang Y.
臺大學術典藏 2022-01-24T09:31:28Z Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer Chang M.-H.; You S.-L.; Chen C.-J.; CHUN-JEN LIU; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; Chen D.-S.; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S.
臺大學術典藏 2022-01-24T09:31:27Z How Does Aging Affect Presentation and Management of Biliary Stones? Hu K.-C.; Chu C.-H.; Wang H.-Y.; Chang W.-H.; Lin S.-C.; Liu C.-C.; Liao W.-C.; CHUN-JEN LIU; Wu M.-S.; Shih S.-C.
臺大學術典藏 2022-01-24T09:31:27Z Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C Mah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:26Z NOhep: Toward Global Control of Hepatitis B Virus Infection - An Introduction CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:26Z Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B Yang H.-C.; Shih Y.-F.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:26Z Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; Su T.-H.; Chen C.-L.; CHUN-JEN LIU; Shih S.-C.
臺大學術典藏 2022-01-24T09:31:26Z Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus Su T.-H.; CHUN-JEN LIU; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:25Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:25Z Synergistic effect of hyperglycemia and Helicobacter pylori infection status on colorectal adenoma risk Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu S.-C.; Liu C.-C.; Su T.-H.; Chen C.-L.; CHUN-JEN LIU; Shih S.-C.
臺大學術典藏 2022-01-24T09:31:25Z Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response Hong C.-M.; CHUN-JEN LIU; Yeh S.-H.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:25Z Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU; Huang C.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:24Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; CHUN-JEN LIU; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:24Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; CHUN-JEN LIU; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:24Z Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study Yu M.-W.; Lin C.-L.; CHUN-JEN LIU; Yang S.-H.; Tseng Y.-L.; Wu C.-F.
臺大學術典藏 2022-01-24T09:31:24Z Combination therapy for chronic hepatitis B: Current updates and perspectives Su T.-H.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:23Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; CHUN-JEN LIU; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:23Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; CHUN-JEN LIU; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J.
臺大學術典藏 2022-01-24T09:31:23Z Mother-to-infant transmission of hepatitis B virus: challenges and perspectives Shih Y.-F.; CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:22Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H.; CHUN-JEN LIU; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:22Z Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment Wong V.W.-S.; Chan W.-K.; Chitturi S.; Chawla Y.; Dan Y.Y.; Duseja A.; Fan J.; Goh K.-L.; Hamaguchi M.; Hashimoto E.; Kim S.U.; Lesmana L.A.; Lin Y.-C.; CHUN-JEN LIU; Ni Y.-H.; Sollano J.; Wong S.K.-H.; Wong G.L.-H.; Chan H.L.-Y.; Farrell G.
臺大學術典藏 2022-01-24T09:31:22Z The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups Chitturi S.; Wong V.W.-S.; Chan W.-K.; Wong G.L.-H.; Wong S.K.-H.; Sollano J.; Ni Y.-H.; CHUN-JEN LIU; Lin Y.-C.; Lesmana L.A.; Kim S.U.; Hashimoto E.; Hamaguchi M.; Goh K.-L.; Fan J.; Duseja A.; Dan Y.Y.; Chawla Y.; Farrell G.; Chan H.L.-Y.

Showing items 206-255 of 543  (11 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page